[go: up one dir, main page]

MX9708401A - Genes reguladores de la cromatina. - Google Patents

Genes reguladores de la cromatina.

Info

Publication number
MX9708401A
MX9708401A MX9708401A MX9708401A MX9708401A MX 9708401 A MX9708401 A MX 9708401A MX 9708401 A MX9708401 A MX 9708401A MX 9708401 A MX9708401 A MX 9708401A MX 9708401 A MX9708401 A MX 9708401A
Authority
MX
Mexico
Prior art keywords
chromatin
regulator genes
genes
deregulation
regulator
Prior art date
Application number
MX9708401A
Other languages
English (en)
Other versions
MXPA97008401A (es
Inventor
Thomas Jenuwein
Gotz Laible
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MXPA97008401A publication Critical patent/MXPA97008401A/es
Publication of MX9708401A publication Critical patent/MX9708401A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invencion se relaciona con la desregulacion de los genes reguladores de la cromatina, los cuales tienen un domino SET, tal desregulacion es de importancia en ciertas condiciones del cáncer. Esos genes, en particular los dominios SET como tales, pueden usarse en el diagnostico y terapia de tales condiciones.
MX9708401A 1995-05-10 1996-05-02 Genes reguladores de la cromatina. MX9708401A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19516776A DE19516776A1 (de) 1995-05-10 1995-05-10 Chromatin-Regulatorgene
DE19516776.7 1995-05-10
PCT/EP1996/001818 WO1996035784A2 (de) 1995-05-10 1996-05-02 Chromatin-regulatorgene

Publications (2)

Publication Number Publication Date
MXPA97008401A MXPA97008401A (es) 1998-02-01
MX9708401A true MX9708401A (es) 1998-02-28

Family

ID=7761318

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9708401A MX9708401A (es) 1995-05-10 1996-05-02 Genes reguladores de la cromatina.

Country Status (11)

Country Link
US (2) US6689583B1 (es)
EP (1) EP0827537B1 (es)
JP (1) JP4295824B2 (es)
AT (1) ATE404667T1 (es)
CA (1) CA2220442C (es)
DE (2) DE19516776A1 (es)
DK (1) DK0827537T3 (es)
ES (1) ES2313726T3 (es)
MX (1) MX9708401A (es)
PT (1) PT827537E (es)
WO (1) WO1996035784A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516776A1 (de) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
US6239327B1 (en) 1998-04-16 2001-05-29 Cold Spring Harbor Laboratory Seed specific polycomb group gene and methods of use for same
CA2366479A1 (en) * 1999-03-11 2000-09-14 Genesis Research And Development Corporation Ltd. Compositions and methods for the modification of gene transcription
US6555329B2 (en) * 2000-06-09 2003-04-29 Boehringer Ingelheim International Gmbh Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
US20020039776A1 (en) 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them
AU2002211624A1 (en) * 2000-10-10 2002-04-22 Genencor International, Inc. Information rich libraries
WO2003000715A1 (en) 2001-06-22 2003-01-03 Ceres, Inc. Chimeric histone acetyltransferase polypeptides
US20040053848A1 (en) * 2001-08-23 2004-03-18 Allis C. David Antibodies specific for methylated lysines in histones
WO2003055506A1 (fr) * 2001-12-27 2003-07-10 Takeda Chemical Industries, Ltd. Medicaments pour la prevention et le traitement du cancer
GB0228900D0 (en) * 2002-12-11 2003-01-15 Ml Lab Plc Cancer Immunotherapy
WO2004058969A1 (ja) * 2002-12-24 2004-07-15 Takeda Pharmaceutical Company Limited がんの予防・治療剤
JPWO2005054467A1 (ja) * 2003-12-03 2007-12-06 中外製薬株式会社 哺乳類βアクチンプロモーターを利用した発現系
JP2005170799A (ja) * 2003-12-08 2005-06-30 Univ Kurume ｚｅｓｔｅホモログ２のエンハンサーのＨＬＡ−Ａ２４結合ペプチド
DE602005017781D1 (de) * 2004-06-01 2009-12-31 Univ North Carolina Rekonstituierter histon-methyltransferase-komplex und verfahren zur identifizierung von modulatoren dafür
WO2007097494A1 (en) * 2006-02-27 2007-08-30 Imgen Co., Ltd. De-differentiation of astrocytes into neural stem cell using bmi-1
US8574832B2 (en) 2010-02-03 2013-11-05 Massachusetts Institute Of Technology Methods for preparing sequencing libraries
US20130195843A1 (en) * 2010-06-23 2013-08-01 British Columbia Cancer Agency Branch Biomarkers for Non-Hodgkin Lymphomas and Uses Thereof
WO2011160206A1 (en) 2010-06-23 2011-12-29 Morin Ryan D Biomarkers for non-hodgkin lymphomas and uses thereof
US9175331B2 (en) 2010-09-10 2015-11-03 Epizyme, Inc. Inhibitors of human EZH2, and methods of use thereof
AU2011298987B2 (en) 2010-09-10 2017-09-28 Epizyme, Inc. Inhibitors of human EZH2, and methods of use thereof
EP2621942A4 (en) * 2010-09-29 2015-01-21 Gen Hospital Corp MEANS FOR PROVIDING CONTROLS AND STANDARDS FOR IMMUNE PRECIPITATION ASSAYS
TWI598336B (zh) 2011-04-13 2017-09-11 雅酶股份有限公司 經取代之苯化合物
JO3438B1 (ar) 2011-04-13 2019-10-20 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
BR112014025508B1 (pt) 2012-04-13 2020-11-17 Eisai R&D Management Co., Ltd. forma de sal de um inibidor de histona metiltransferase ezh2 humana
JP6461803B2 (ja) 2012-10-15 2019-01-30 エピザイム，インコーポレイティド 置換ベンゼン化合物
WO2014153030A2 (en) 2013-03-14 2014-09-25 Genentech, Inc. Methods of treating cancer and preventing cancer drug resistance
CN103215352B (zh) * 2013-03-29 2015-03-11 中国医学科学院血液病医院（血液学研究所） 一种检测setd2基因突变的试剂盒
EA038869B1 (ru) 2013-10-16 2021-10-29 Эпизим, Инк. Кристаллические формы гидрохлорида n-((4,6-диметил-2-оксо-1,2-дигидропиридин-3-ил)метил)-5-(этил(тетрагидро-2h-пиран-4-ил)амино)-4-метил-4'-(морфолинометил)-[1,1'-бифенил]-3-карбоксамида, фармацевтические композиции на их основе и способы их применения

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486623A (en) 1993-12-08 1996-01-23 Prototek, Inc. Cysteine protease inhibitors containing heterocyclic leaving groups
DE19516776A1 (de) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
WO1998027994A1 (en) 1996-12-20 1998-07-02 Board Of Regents, The University Of Texas System Proteins and compositions for modulating mitosis
US6004933A (en) 1997-04-25 1999-12-21 Cortech Inc. Cysteine protease inhibitors
US5972608A (en) 1997-08-27 1999-10-26 University Of Massachusetts Assays and reagents for chromatin remodeling enzymes and their modulators
EP1029547A1 (en) 1999-02-15 2000-08-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Pharmaceutically active compounds and method for identifying same
US20020039776A1 (en) 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them
US6555329B2 (en) 2000-06-09 2003-04-29 Boehringer Ingelheim International Gmbh Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
US20020164620A1 (en) 2001-01-19 2002-11-07 Boehringer Ingelheim International Gmbh Method for identifying compounds modulating sister chromatid separation
EP1227160A1 (en) 2001-01-19 2002-07-31 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Compounds modulating sister chromatid separation and method for identifying same
MXPA03009877A (es) 2001-05-04 2005-07-15 Univ Florida Clonacion y secuenciamiento de genes de piruvato decarboxilasa (pdc) a partir de bacterias y usos de los mismos.

Also Published As

Publication number Publication date
US20050089880A1 (en) 2005-04-28
PT827537E (pt) 2008-10-09
DE59611481D1 (en) 2008-09-25
US7252968B2 (en) 2007-08-07
CA2220442C (en) 2011-07-12
ATE404667T1 (de) 2008-08-15
EP0827537A2 (de) 1998-03-11
ES2313726T3 (es) 2009-03-01
CA2220442A1 (en) 1996-11-14
DK0827537T3 (da) 2008-12-01
WO1996035784A3 (de) 1996-12-27
JP4295824B2 (ja) 2009-07-15
JP2001505402A (ja) 2001-04-24
US6689583B1 (en) 2004-02-10
EP0827537B1 (de) 2008-08-13
WO1996035784A2 (de) 1996-11-14
DE19516776A1 (de) 1996-11-14

Similar Documents

Publication Publication Date Title
MX9708401A (es) Genes reguladores de la cromatina.
WO2001023405A3 (en) Therapeutic treatment of androgen receptor driven conditions
DE69830072D1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
AU2592600A (en) Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
IL147017A0 (en) TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES
WO2000028090A3 (en) Diagnostic assay for cancer
PT1187632E (pt) Tratamento com anticorpos anti-erbb2
DE69703294D1 (de) Zusammensetzungen die konjugate von cis-docosahexaenoic-säure und taxotere enthalten
AU2386201A (en) Substituted sapogenins and their use
DE69518919D1 (de) Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
IL187254A (en) ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB
PL330496A1 (en) Methods of and compositions for treating and preventing tumours, disorders associated with tumours as well as cachexy
UA66793C2 (uk) Лептин як стримувач швидкого збільшення пухлини клітини
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
HUP0104688A2 (hu) Összetételek és eljárások a rákbetegség és a rákbetegséggel kapcsolódó csontveszteség megelőzéséhez és kezeléséhez
BR9808606A (pt) Materiais e métodos para tratamento de doenças com ribozimas
AU2821295A (en) Compositions and methods for the treatment of tumors
GB9923078D0 (en) Sapogenin derivatives and their use
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
AU6849198A (en) Neurotrypsin
AU1278600A (en) Novel therapeutic application of nicergoline
IL139144A0 (en) Mycobacterial inhibitors
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
AU7402600A (en) New sequence variants of the human beta1-adrenoreceptor genes and use thereof